URV researchers are taking part in a pioneering study that analyses the behavioural and molecular effects in the short, medium and long term resulting from exposure to chlorpyrifos, which may be related to hyperactivity, autism and addictions
Show all news
These installations centralize large scale heating and the production of hot water. One study led by researchers from the URV has created a diagnostic tool that uses artificial intelligence to demonstrate the feasibility of these systems
An international team of researchers advocates the use of UV-C light in indoor spaces as a way to reduce the transmission of SARS-CoV-2 viruses. This solution meets the requirements of fast, scalable, and affordable implementation to fulfill the needs of disinfecting working spaces
11/06/2020
Choosing the city, choosing the URV
I had to stay in Tarragona during the confinement because all the flights back to Turkey were cancelled and all the borders were closed
The European Commission has awarded the URV’s Martí i Franquès programme more than four million euros to be used to contract 50 predoctoral researchers. The selection process will take place over two editions in 2020 and 2021, and the chosen candidates will each be awarded a three-year contract. The university will contribute a further four million euros to the project. The URV is one of three institutions in Spain to have received funding in the last call of the European Commission’s COFUND-DP programme, and it is the one that has received the most money
09/06/2020
Living through the pandemic away from home
International students who have remained in Tarragona and local students who have not been able to return home at the end of their studies abroad describe their lockdown experiences
URV researchers have developed a nanometric-scale theoretical model to create structures that kill bacteria by using elastic forces. The results of this study pave the way to creating new antibacterial materials
Large scale testing of the device is underway; in only 15 minutes and with just a single pinprick of blood it can determine with 100% reliability if a person has the disease or if they have developed antibodies to it
A study by the URV’s Cheminformatics and Nutrition research group has shown that an anti-inflammatory drug for humans and another for animals inhibit a key enzyme in the replication and transcription of the COVID-19 virus. The results of the work have been validated by the initiative COVIDMoonshot which has carried out in vitro studies and assessed their bioactivity. The results have been published in the “International Journal of Molecular Sciences”
The research opens the door to developing more natural drugs that are less toxic for patients with cancer. The results of this study led by researchers from the URV have been published in the journal Scientific Reports